Stonepine Capital Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Stonepine Capital Management, LLC
- $126 Billion
- Q1 2024
A detailed history of Stonepine Capital Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 1,462,296 shares of MIST stock, worth $2.19 Million. This represents 2.08% of its overall portfolio holdings.
Number of Shares
1,462,296Holding current value
$2.19 Million% of portfolio
2.08%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
47Shares Held
31.3MCall Options Held
3.3KPut Options Held
3.5K-
Black Rock Inc. New York, NY4.97MShares$7.46 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.88 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.86MShares$4.28 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.37MShares$3.56 Million2.21% of portfolio
-
Lion Point Capital, LP New York, NY2.3MShares$3.45 Million2.63% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $45M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...